- Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Sørensen, K.D., Wild, P.J., Mortezavi, A., Adolf, K., Tørring, N., Heebøll, S., Ulhøi, B.P., Ottosen, P., Sulser, T., Hermanns, T., Moch, H., Borre, M., Ørntoft, T.F., Dyrskjøt, L. Clin. Cancer Res. (2009)